
Metabolic & digestive pharmaceuticals revenue in Argentina 2017-2021
In the fourth quarter of 2021, the revenue of the metabolic and digestive pharmaceutical industry in Argentina amounted to more than 28 billion Argentine pesos, up from over 25 billion pesos reported in the previous quarter. The revenues of this type of pharmaceutical in the South American country have been increasing since the first quarter of 2018, when it amounted to 3.8 billion pesos.